| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Jie Li | Q89518299 |
| P2093 | author name string | Feng Cao | |
| Gang Wang | |||
| Ning Mao | |||
| Bei Sun | |||
| He-Liang Yin | |||
| Zhi-Tao Lin | |||
| Zi-Jian Huang | |||
| P2860 | cites work | Molecular characterization of mitochondrial apoptosis-inducing factor | Q22001452 |
| AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis | Q24295497 | ||
| CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth | Q24296787 | ||
| Dysregulation of glutathione homeostasis in neurodegenerative diseases | Q26822726 | ||
| Characterization of mammalian selenoproteomes. | Q27863319 | ||
| HSPB1 as a novel regulator of ferroptotic cancer cell death | Q28258033 | ||
| Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis | Q28384683 | ||
| Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice | Q28396141 | ||
| Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells | Q28397198 | ||
| Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth | Q30828545 | ||
| Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells | Q30844792 | ||
| Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. | Q31058247 | ||
| Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells | Q33324778 | ||
| Regulation of ferroptotic cancer cell death by GPX4 | Q33826380 | ||
| Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis | Q33897013 | ||
| Ferroptosis: an iron-dependent form of nonapoptotic cell death | Q34032093 | ||
| Ferroptosis as a p53-mediated activity during tumour suppression | Q34043533 | ||
| Glutaminolysis and Transferrin Regulate Ferroptosis | Q34044434 | ||
| Ferroptosis: Death by Lipid Peroxidation | Q34045575 | ||
| Ferroptosis: process and function | Q34045909 | ||
| Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models | Q34408158 | ||
| Synchronized renal tubular cell death involves ferroptosis. | Q34447203 | ||
| RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels | Q34618715 | ||
| Iron accumulates in Huntington's disease neurons: protection by deferoxamine | Q35023030 | ||
| Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms. | Q35296244 | ||
| Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death | Q36414474 | ||
| Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease | Q36665139 | ||
| Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses | Q36780705 | ||
| The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents | Q36997966 | ||
| Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells | Q37022006 | ||
| Autophagy promotes ferroptosis by degradation of ferritin | Q37141766 | ||
| Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke | Q37312849 | ||
| The Role of Reactive Oxygen Species and Ferroptosis in Heme-Mediated Activation of Human Platelets | Q88993613 | ||
| CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer | Q89179081 | ||
| Cell Death Pathways Drive Necroinflammation during Acute Kidney Injury | Q89365807 | ||
| Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells | Q90048390 | ||
| Recent Progress in Ferroptosis Inducers for Cancer Therapy | Q90601782 | ||
| Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis | Q90702153 | ||
| FSP1 is a glutathione-independent ferroptosis suppressor | Q90850050 | ||
| The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis | Q90850055 | ||
| Role of ferroptosis in hepatocellular carcinoma | Q91243890 | ||
| Chaperone-mediated autophagy is involved in the execution of ferroptosis | Q91340147 | ||
| Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage | Q91386173 | ||
| Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation | Q92109247 | ||
| Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses | Q37398094 | ||
| Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis | Q37543809 | ||
| The transsulfuration pathway: a source of cysteine for glutathione in astrocytes | Q37849215 | ||
| The regulation of iron transport. | Q38153305 | ||
| Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI. | Q39648552 | ||
| Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate | Q39996069 | ||
| Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells | Q40658370 | ||
| Iron addiction: a novel therapeutic target in ovarian cancer | Q41211121 | ||
| Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration | Q41825693 | ||
| Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration | Q42321081 | ||
| Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells | Q42430876 | ||
| Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging | Q43509556 | ||
| Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study | Q45306906 | ||
| Potentiation of glutathione loss and nerve cell death by the transition metals iron and copper: Implications for age-related neurodegenerative diseases | Q46255147 | ||
| Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells | Q46260326 | ||
| Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke. | Q46269921 | ||
| Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells | Q46328831 | ||
| The Impact of DIDS-Induced Inhibition of Voltage-Dependent Anion Channels (VDAC) on Cellular Response of Lymphoblastoid Cells to Ionizing Radiation. | Q46380063 | ||
| Friedreich ataxia-induced pluripotent stem cell-derived neurons show a cellular phenotype that is corrected by a benzamide HDAC inhibitor | Q46421445 | ||
| Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children | Q46557394 | ||
| The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells | Q46807686 | ||
| NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis | Q47371292 | ||
| CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway. | Q47642087 | ||
| The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity | Q47945423 | ||
| miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. | Q48214977 | ||
| p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells | Q49200611 | ||
| Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis | Q49379289 | ||
| Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma | Q50147318 | ||
| Heme Oxygenase-1 Mitigates Ferroptosis in Renal Proximal Tubule Cells. | Q50640125 | ||
| Ferroptosis: A Novel Anti-Tumor Action for Cisplatin. | Q51008237 | ||
| CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. | Q51579570 | ||
| Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC. | Q53085614 | ||
| Oxytosis/Ferroptosis-(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System. | Q54946045 | ||
| Ferroptosis-inducing agents compromise in vitro human islet viability and function. | Q55025225 | ||
| Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. | Q55527156 | ||
| N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with PGE to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice | Q57182391 | ||
| P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation | Q57463249 | ||
| The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma | Q57903458 | ||
| Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer | Q58553382 | ||
| Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy | Q58585327 | ||
| Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer | Q61203483 | ||
| Ferroptosis as a target for protection against cardiomyopathy | Q61808556 | ||
| Inhibition of ferroptosis attenuates tissue damage and improves long-term outcomes after traumatic brain injury in mice. | Q64883818 | ||
| Inhibition of selenoprotein synthesis by selenocysteine tRNA[Ser]Sec lacking isopentenyladenosine | Q73815535 | ||
| Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically | Q88292931 | ||
| Iron and Alzheimer's Disease: An Update on Emerging Mechanisms | Q88978904 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P433 | issue | 2 | |
| P921 | main subject | pharmacology | Q128406 |
| molecular biology | Q7202 | ||
| Ferroptosis | Q55446273 | ||
| P304 | page(s) | 88 | |
| P577 | publication date | 2020-02-03 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Ferroptosis: past, present and future | |
| P478 | volume | 11 |
| Q98502789 | Circular RNA cIARS regulates ferroptosis in HCC cells through interacting with RNA binding protein ALKBH5 |
| Q100332922 | Crosstalk Between Autophagy and Ferroptosis and Its Putative Role in Ischemic Stroke |
| Q98226249 | Ferroptosis in Acute Central Nervous System Injuries: The Future Direction? |
| Q91813228 | Iron overload contributes to general anaesthesia-induced neurotoxicity and cognitive deficits |
| Q97593160 | Molecular Mechanisms of Ferroptosis and Its Role in Pulmonary Disease |
| Q101455784 | Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins |
| Q103728445 | SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement? |
| Q99616624 | Together we stand, apart we fall: how cell-to-cell contact/interplay provides resistance to ferroptosis |
| Q99548916 | mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer |
| Q94671691 | p53: 800 million years of evolution and 40 years of discovery |
Search more.